SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Senesco Technologies, Inc. Announces Expansion of Phase 1b/2a Study to Include Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma